Toxicity of the hematopoietically active bone marrow continues to be a primary limitation in radionuclide therapies of cancer. Improved techniques for patient-specific skeletal dosimetry are thus crucial to the development of dose–response relationships needed to optimize these therapies (i.e., avoid both marrow toxicity and tumor underdosing). Current clinical methods of skeletal dose assessment rely heavily on a single set of bone and marrow cavity chord-length distributions in which particle energy deposition is tracked within an infinite extent of trabec-ular spongiosa, with no allowance for particle escape to cortical bone. In the present study, we introduce a paired-image radia-tion transport (PIRT) model that can provide a more reali...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
Cone beam computed tomography (CBCT) is a relatively new patient imaging technique that has proved i...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...
-Particles are of current interest in radionuclide therapy due to their short range and high rates o...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
Objective of the study: to develop a skeleton model for assessing red bone marrow dose from osteotro...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The toxicity of red bone marrow is widely considered to be a key factor in restricting the activity ...
Bone marrow is generally the dose-limiting organ of concern in radioimmunotherapy and in radionuclid...
ABSTRACT The University of Florida (UF) proposes to develop two high-resolution image-based skeletal...
Nuclear medicine encompasses numerous steps, with accuracy being a key component throughout. Exactit...
Purpose: To evaluate a three-equation three-unknown dual-energy quantitative CT (DEQCT) technique fo...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
Cone beam computed tomography (CBCT) is a relatively new patient imaging technique that has proved i...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...
-Particles are of current interest in radionuclide therapy due to their short range and high rates o...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
Objective of the study: to develop a skeleton model for assessing red bone marrow dose from osteotro...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The toxicity of red bone marrow is widely considered to be a key factor in restricting the activity ...
Bone marrow is generally the dose-limiting organ of concern in radioimmunotherapy and in radionuclid...
ABSTRACT The University of Florida (UF) proposes to develop two high-resolution image-based skeletal...
Nuclear medicine encompasses numerous steps, with accuracy being a key component throughout. Exactit...
Purpose: To evaluate a three-equation three-unknown dual-energy quantitative CT (DEQCT) technique fo...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
Cone beam computed tomography (CBCT) is a relatively new patient imaging technique that has proved i...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...